Form 8-K - Current report:
SEC Accession No. 0001493152-24-045422
Filing Date
2024-11-14
Accepted
2024-11-14 09:28:43
Documents
17
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41293
2 ex99-1.htm EX-99.1 86946
3 ex99-1_001.jpg GRAPHIC 18694
4 ex99-1_002.jpg GRAPHIC 14677
  Complete submission text file 0001493152-24-045422.txt   411386

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20241114.xsd EX-101.SCH 3785
6 XBRL DEFINITION FILE biaf-20241114_def.xml EX-101.DEF 30033
7 XBRL LABEL FILE biaf-20241114_lab.xml EX-101.LAB 36673
8 XBRL PRESENTATION FILE biaf-20241114_pre.xml EX-101.PRE 27056
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 241457774
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)